Ireland Pacemaker Market to be Dominated by the Implantable Segment by 2028
The growing cases of
cardiovascular conditions, such as arrhythmias and bradycardia, are expected to
drive the Ireland Pacemaker Market in the forecast period from 2024 to 2028.
According to TechSci Research
report, “Ireland Pacemaker– By Region, Competition Forecast and
Opportunities, 2018-2028,” the Ireland Pacemaker Market is anticipated to
grow at a steady rate in the forecast period of 2024-2028. This can be
attributed to the increasing incidence of cardiac diseases, growing awareness
among the population regarding heart issues, and the rise in research and
development, among other factors. In Ireland, cardiovascular illnesses are the
leading cause of death, with risk factors such as smoking, high blood pressure,
and diabetes being very common. To address these diseases, there is an
increasing demand for cardiac interventions, such as pacemakers, which is
expected to propel the demand for the Ireland Pacemaker Market in the forecast
period.
The pacemaker industry is
constantly evolving, with the development of new technologies such as wireless
pacemakers and pacemakers with advanced sensors that enhance the safety,
efficacy, and functionality of pacemakers. As a result of these advancements,
the demand for pacemakers is rising as patients and healthcare professionals
seek the newest and most innovative devices. The development of pacemakers that
are MRI-compatible and Bluetooth-enabled, for example, is improving the
efficiency and compatibility of pacemakers with patients. This makes it easier
and more efficient for patients to monitor their health conditions, thus
contributing to the growth of the Ireland Pacemaker Market.
Moreover, there is growing
awareness among the public and healthcare providers in Ireland regarding the
benefits of pacemakers in managing cardiac conditions. This increased awareness
is leading to the growth of the Ireland Pacemaker Market.
However, pacemakers are costly
and due to a lack of skilled personnel, they act as a restraining factor to the
growth of the Ireland Pacemaker Market.
Browse over XX market data
Figures spread through XX Pages and an in-depth TOC on "Ireland Pacemaker Market.”
Based on application, the market
is segmented into Arrhythmias, Congestive Heart Failure, and Others. The
arrhythmias segment dominated the market in 2022 and is expected to hold the
highest market share in the forecast period. This is due to the rise in
lifestyle disorders, excessive alcohol consumption, smoking, obesity, etc.
Based on product type, the market
is segmented into conventional and MRI compatible. The MRI compatible segment
dominated in 2022 and is expected to hold the highest share in the forecast
period. This is due to the increase in demand for MRI-based diagnosis and
advancements in technology. Hence, the segment is experiencing the highest
growth due to increased MRI diagnoses in patients suffering from cardiac
conditions such as arrhythmias.
Based on end user, the market is
further segmented into hospitals, cardiac care centers, and ambulatory surgical
centers. The hospitals segment dominated in 2022 and is expected to hold the
highest share in the coming years. This is attributed to the increase in the
number of hospitals and the surge in the number of cardiac surgical procedures.
However, ambulatory surgical centers will witness considerable growth during
the forecast period due to the rise in the prevalence of heart disease, development
in ambulatory surgical centers, and government initiatives for the growth of
the healthcare sector.
Major companies operating in the Ireland Pacemaker Market
are:
- Abbott Ireland Limited
- Cook Group (Ireland)
- Boston Scientific Ireland Ltd
- Medtronic Ireland Ltd
- LivaNova Ireland Limited
- Integer Ireland Medical Ltd
Download Free Sample Report
Customers can also request
for 10% free customization on this report.
“The growth of the pacemaker
market in Ireland can be attributed to a number of factors. The prevalence of
cardiovascular diseases is on the rise. The Irish population is aging faster
than the rest of the world. The pacemaker market is dominated by well-known
companies such as Medtronic (Medtronic), Boston Scientific (Boston Scientific),
and Abbott Laboratories (Abbott Laboratories). These companies are constantly
innovating to improve the device performance, the battery life, and the remote
monitoring capabilities of their pacemakers. In addition to this, new
technological developments such as lead-free pacemakers, and MRI-compatible
pacemakers are becoming increasingly popular. These devices are safer and more
convenient for patients. The pacemaker market is also driven by the trend
towards personalized medicine. This means that pacemaker settings are designed
to meet the specific needs of each patient and ensure optimal cardiac rhythm
management.," said Mr. Karan Chechi, Research Director at TechSci
Research, a research-based global management consulting firm.
“Ireland Pacemaker Market By
Type (Implantable, External), By Technology (Single Chamber, Dual Chamber,
Biventricular Chamber), By Product Type (Conventional, MRI Compatible), By
Application (Arrhythmias, Congestive Heart Failure, Others), By End User
(Hospitals, Cardiac Care Centers, Ambulatory Surgical Centers), By Region,
Competition Forecast & Opportunities, 2028,” has evaluated the future
growth potential of Ireland Pacemaker Market and provides statistics &
information on market size, structure, and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in Ireland Pacemaker Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com